These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10078920)

  • 1. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
    Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV
    Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
    Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
    Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade?
    Brinker DA; Ross JS; Tran TA; Jones DM; Epstein JI
    J Urol; 1999 Dec; 162(6):2036-9. PubMed ID: 10569563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?
    Lo J; Kerns BJ; Amling CL; Robertson CN; Layfield LJ
    J Surg Oncol; 1996 Sep; 63(1):41-5. PubMed ID: 8841465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
    Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
    Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
    Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
    Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
    Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
    Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.
    Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L
    Scand J Urol Nephrol; 2005; 39(5):387-92. PubMed ID: 16257840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
    Carmichael MJ; Veltri RW; Partin AW; Miller MC; Walsh PC; Epstein JI
    J Urol; 1995 Mar; 153(3 Pt 2):1015-9. PubMed ID: 7853549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy.
    Brown JA; Slezak JM; Lieber MM; Jenkins RB
    Mayo Clin Proc; 1999 Dec; 74(12):1214-20. PubMed ID: 10593349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
    Badalament RA; O'Toole RV; Young DC; Drago JR
    Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative histological and cytological diagnosis and DNA ploidy assessment of localized prostatic cancer. A comparison between findings in biopsies and total prostatectomy specimens.
    Häggman M; de la Torre M; Norberg M; Busch C
    APMIS; 1994 Nov; 102(11):841-8. PubMed ID: 7833004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
    Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
    Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
    Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
    Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?
    Smith EB; Frierson HF; Mills SE; Boyd JC; Theodorescu D
    Cancer; 2002 Apr; 94(8):2282-7. PubMed ID: 12001128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyribonucleic acid ploidy status as no basis for pathologic stage prediction in clinically resectable prostate cancer.
    Egawa S; Satoh T; Iwamura M; Aihara M; Kuwao S; Uchida T; Koshiba K
    Urology; 1996 Apr; 47(4):548-52. PubMed ID: 8638366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age.
    Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ
    Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy?
    Rubin MA; Dunn R; Kambham N; Misick CP; O'Toole KM
    Am J Surg Pathol; 2000 Dec; 24(12):1634-40. PubMed ID: 11117784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.